Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: heart + levitra + 0.23  Related to the article below (Last Update: 8/7/2008)

Better Sex For Couples
SkyNewswire.com (press release), Netherlands - 59 minutes ago
Included in this class are the drugs Viagra, Cialis, and Levitra. They are effective in treating impotence because they cause more complete filling of the ...
Going-Concern Statement
FOXBusiness -
People taking REYATAZ should speak with their healthcare provider before taking the following medicines: Viagra(R) (sildenafil), Levitra(R) (vardenafil), ...BMY
WKU To Induct Three Into Hall Of Distinguished Alumni
Amplifier, KY -
The next time you see an advertisement for Viagra, Cialis, Levitra or Revatio, you can thank Sharron H. Francisfrancis for her role in research that led to ...
Impotence drugs help treat brain tumours
Reuters - Jul 28, 2008
Levitra and Viagra, known generically as sildenafil, are in a class of drugs known as PDE5 inhibitors. They were originally tested as heart drugs because ...
Reuters Health News Summary
San Diego Union Tribune, United States - Jul 29, 2008
N) Levitra and Pfizer's (PFE.N) Viagra ? helped carry a chemotherapy drug past the blood-brain barrier, the team at Cedars-Sinai Medical Center in Los ...
Erectile Dysfunction Drugs Used in Chemotherapy Treatment
ShortNews.com, Germany - Jul 29, 2008
... rate and healthy brain tissue is not affected. Viagra and Levitra were originally used as heart drugs to increase the blood flow to small blood vessels.
London Duo Sentenced For Trafficking Counterfeit Medicines And ...
Medical News Today (press release), UK - Jul 10, 2008
Plavix is used to treat heart attacks and strokes. Levitra, Viagra and Cialis are used to treat erectile dysfunction. 2. If an individual is convicted of ...
ED treatment risky with cardiac disease
News Sentinel, IN - Jul 14, 2008
... like diabetes or heart disease? ? Jim, Syracuse, NY A: The major side effect of these drugs ? mainly Viagra, Cialis and Levitra ? is that 100 people die ...
A new passion fruit: Watermelon contains ingredients that could ...
The North Bay Nugget, Canada - Jul 15, 2008
Viagra, or drugs which cause the same effects including Cialis or Levitra, need to be prescribed by a doctor and are only covered under certain drug plans. ...
Source: Google News

Phosphodiesterase-5 inhibitors for male erectile dysfunction -
Z Sui - etp, 2003 - Expert Opinion
... for MED treat- ment, many of these compounds are scientifically capable of becoming
drugs for MED, as evidenced by the recent launches of vardenafil (Levitra ...

Phosphodiesterase-5 inhibitors for male erectile dysfunction
M Focus, I Biologicals, D Delivery - Expert Opin. Ther. Patents, 2003 - Expert Opinion
... for MED treat- ment, many of these compounds are scientifically capable of becoming
drugs for MED, as evidenced by the recent launches of vardenafil (Levitra ...
-

AUTHOR AND EDITOR INFORMATION
UA Blackstock - emedicine.com
... negative LR = 0.33; 95% CI, 0.23-0.48 ... and decrease in symptoms from heart failure. ...
vasodilators (eg, sildenafil [Viagra], vardenafil [Levitra]), especially when ...
-

13 PDE11
K Omori, J Kotera - Cyclic Nucleotide Phosphodiesterases in Health and Disease, 2006 - books.google.com
... Viagra, Pfizer Inc., New York, NY), vardenafil (Levitra, Bayer AG ... N/A N/A N/A
3.8?0.75 3.15?0.23 N/A ... to be absent in the bladder, colon, heart, small intestine ...
-

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus (Review) -
M Vardi, A Nini - doi.wiley.com
... The introduction of sildenafil (Viagra), vardenafil (Levitra) and tadalafil
(Cialis), have altered the management of erectile dysfunction. ...
-

Synthesis and SAR of tetracyclic pyrroloquinolones as phosphodiesterase 5 inhibitors -
W Jiang, VC Alford, Y Qiu, S Bhattacharjee, TM … - Bioorganic & Medicinal Chemistry, 2004 - Elsevier
... 6] such as recently launched Levitra? (vardenafil) [5 ... 5, and 6 were isolated from
human heart, corpus cavernosum ... of KOtBu was neutralized by HCl (0.23 mL, 2.0 M ...

AUTHOR AND EDITOR INFORMATION -
F Dangond - emedicine.com
... in the EDSS of -0.13 compared with placebo (0.23), an ambulation ... dysfunction -
Sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), alprostadil (Muse ...
-

A quantitative approach to probe the dependence and correlation of food-effect with aqueous … -
BN Singh - Drug Dev. Res, 2005 - doi.wiley.com
... within which a drug is not expected to be significantly affected by food falls between
0.148?89.39 mg/ml for aqueous solubility and between 0.23?624 ml for ...

The Partiality of Humanitarian Assistance: Kosovo in Comparative Perspective
T Porter - Journal of Humanitarian Assistance, 2000 - jha.ac
... suffering be reconciled with the principle of universality that lies at the heart
of the ... been a steady decline over the past decade to a figure of 0.23% in 1998 ...

Structural and Functional Features in Human PDE5A1 Regulatory Domain That Provide for Allosteric … -
R Zoraghi, EP Bessay, JD Corbin, SH Francis - Journal of Biological Chemistry, 2005 - ASBMB
... PDE5 is the target of sildenafil (Viagra TM ), tadalafil (Cialis TM ), and vardenafil
(Levitra TM ), all of which are in use for treatment of maladies ...

Source: Google Scholar
 
 

Levitra may protect the heart following acute myocardial infarction

Researchers at Virginia Commonwealth University ( VCU ) found that Levitra ( Vardenafil ), an erectile dysfunction drug, protects the heart against tissue damage following acute myocardial infarction.

" Our findings further support the concept that the novel class of phosphodiesterase-5 inhibitors, or PDE-5 inhibitors, including Levitra and Viagra ( Sildenafil ), may have a new utility in cardiac protection, in addition to their well-known use for the management of erectile dysfunction in men," said Rakesh C. Kukreja, at VCU. Kukreja is lead author of the study.

In the study, published in the Journal of Molecular and Cellular Cardiology, Kukreja and his team demonstrated for the first time that pretreatment with a clinically relevant dose of Vardenafil induces a protective effect against myocardial infarction injury by opening the mitochondrial KATP channel in an animal model.

According to Kukreja, PDE-5 is an enzyme responsible for the destruction of cGMP, an intracellular messenger molecule, in heart cells.
The mitochondrial KATP channel and cGMP play an important role in preconditioning of the heart following a myocardial infarction.
The cGMP also has a hand in the dilation of arteries in the body.
PDE-5 inhibitor drugs, such as Vardenafil, Sildenafil, and Tadalafil ( Cialis ) are able to preserve cGMP, and therefore dilation of the arteries by inhibiting PDE-5.

Vardenafil, like Sildenafil, stabilizes the mitochondria and protects against damage of the heart by opening the mitochondrial KATP channels in cardiac cells.

" This study provides important information about the mechanism by which the PDE-5 inhibitors work. Furthermore, it is proof that the positive findings of prior studies on Sildenafil extend to another PDE-5 inhibitor," said George Vetrovec, at VCU's School of Medicine.

Vetrovec suggested that PDE-5 inhibitors such as Sildenafil and Vardenafil may one day be given to patients who are at high risk for acute myocardial infarction or prior to undergoing coronary artery bypass surgery to optimize heart protection.

In addition, Kukreja said that the PDE-5 inhibitors may be developed for future use to protect the brain, liver and other organs against ischemic injury.

Source: Virginia Commonwealth University, 2006

 
 
 
Google
Web www.iconocast.com
 
 

 

Continue News With: News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 © 2002-2006

Keywords::

Contact Iconocast

Home Page